CD24 and breast carcinoma: To identify regulatory molecules in BCSCs, we sorted HMLER, a human breast cancer cell line often used in CSC studies23, into a CD44+CD24− (termed as CD44H subsequently) subpopulation and a CD44−CD24+ (termed as CD44L subsequently) subpopulation via flow cytometry (Fig. 1a).